Literature DB >> 27267863

Melatonin regulates catecholamine biosynthesis by modulating bone morphogenetic protein and glucocorticoid actions.

Motoshi Komatsubara1, Takayuki Hara1, Takeshi Hosoya1, Kishio Toma1, Naoko Tsukamoto-Yamauchi1, Nahoko Iwata2, Kenichi Inagaki1, Jun Wada1, Fumio Otsuka3.   

Abstract

Melatonin is functionally involved in the control of circadian rhythm and hormonal secretion. In the present study, we investigated the roles of melatonin in the interaction of catecholamine synthesis with adrenocortical steroids by focusing on bone morphogenetic protein (BMP)-4 expressed in the adrenal medulla using rat pheochromocytoma PC12 cells. Melatonin treatment significantly reduced the mRNA expression of catecholamine synthases, including the rate-limiting enzyme tyrosine hydroxylase (Th), 3,4-dihydroxyphenylalanine decarboxylase and dopamine-β-hydroxylase expressed in PC12 cells. In accordance with changes in the expression levels of enzymes, dopamine production and cAMP synthesis determined in the culture medium and cell lysate were also suppressed by melatonin. The MT1 receptor, but not the MT2 receptor, was expressed in PC12 cells, and luzindole treatment reversed the inhibitory effect of melatonin on Th expression, suggesting that MT1 is a functional receptor for the control of catecholamine synthesis. Interestingly, melatonin enhanced the inhibitory effect of BMP-4 on Th mRNA expression in PC12 cells. Melatonin treatment accelerated BMP-4-induced phosphorylation of SMAD1/5/8 and transcription of the BMP target gene Id1. Of note, melatonin significantly upregulated Alk2 and Bmpr2 mRNA levels but suppressed inhibitory Smad6/7 expression, leading to the enhancement of SMAD1/5/8 signaling in PC12 cells, while BMP-4 did not affect Mt1 expression. Regarding the interaction with adrenocortical steroids, melatonin preferentially enhanced glucocorticoid-induced Th mRNA through upregulation of the glucocorticoid receptor and downregulation of Bmp4 expression, whereas melatonin repressed Th mRNA expression induced by aldosterone or androgen without affecting expression levels of the receptors for mineralocorticoid and androgen. Collectively, the results indicate that melatonin plays a modulatory role in catecholamine synthesis by cooperating with BMP-4 and glucocorticoid in the adrenal medulla. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone morphogenetic protein; Catecholamine; Glucocorticoid; Melatonin; PC12; Pheochromocytoma

Mesh:

Substances:

Year:  2016        PMID: 27267863     DOI: 10.1016/j.jsbmb.2016.06.002

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  7 in total

Review 1.  A Review of the Potential Effects of Melatonin in Compromised Mitochondrial Redox Activities in Elderly Patients With COVID-19.

Authors:  Wen-Lin Su; Chia-Chao Wu; Shu-Fang Vivienne Wu; Mei-Chen Lee; Min-Tser Liao; Kuo-Cheng Lu; Chien-Lin Lu
Journal:  Front Nutr       Date:  2022-06-20

2.  Melatonin Stimulates STAR Expression and Progesterone Production via Activation of the PI3K/AKT Pathway in Bovine Theca Cells.

Authors:  Xiaomei Wang; Kai Meng; Yuanyuan He; Hengqin Wang; Yong Zhang; Fusheng Quan
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

Review 3.  Benefits and adverse events of melatonin use in the elderly (Review).

Authors:  Lucreția Anghel; Liliana Baroiu; Corina Rișcă Popazu; Diana Pătraș; Silvia Fotea; Alexandru Nechifor; Anamaria Ciubara; Luiza Nechita; Carmina Liana Mușat; Ioana Anca Stefanopol; Alin Laurențiu Tatu; Alexandru Bogdan Ciubara
Journal:  Exp Ther Med       Date:  2022-01-14       Impact factor: 2.447

Review 4.  Modulation of bone morphogenetic protein activity by melatonin in ovarian steroidogenesis.

Authors:  Fumio Otsuka
Journal:  Reprod Med Biol       Date:  2018-02-26

Review 5.  General Adaptation in Critical Illness: Glucocorticoid Receptor-alpha Master Regulator of Homeostatic Corrections.

Authors:  Gianfranco Umberto Meduri; George P Chrousos
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-22       Impact factor: 5.555

6.  Relationship Between Serum Norepinephrine Levels at ICU Admission and the Risk of ICU-Acquired Delirium: Secondary Analysis of the Melatonin Evaluation of Lowered Inflammation of ICU Trial.

Authors:  Yuma Yasuda; Mitsuaki Nishikimi; Kazuki Nishida; Kunihiko Takahashi; Atsushi Numaguchi; Michiko Higashi; Shigeyuki Matsui; Naoyuki Matsuda
Journal:  Crit Care Explor       Date:  2020-02-24

Review 7.  Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS.

Authors:  Gianfranco Umberto Meduri; Djillali Annane; Marco Confalonieri; George P Chrousos; Bram Rochwerg; Amanda Busby; Barbara Ruaro; Bernd Meibohm
Journal:  Intensive Care Med       Date:  2020-11-04       Impact factor: 41.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.